In This Article:
Analysts are bullish on these following companies: TPI Enterprises, West African Resources, Viralytics. These companies are relatively strong financially, and have a great outlook in terms of profits and cash flow. If a buoyant growth prospect is what you’re after in your next investment, I’ve put together a list of high-growth stocks you may be interested in, based on the latest financial data from each company.
TPI Enterprises Limited (ASX:TPE)
TPI Enterprises Limited manufactures and supplies alkaloids in Australia and internationally. The company was established in 2004 and with the company’s market capitalisation at AUD A$122.03M, we can put it in the small-cap group.
Driven by exceptional sales, which is expected to more than double over the next few years, TPE is expected to deliver an excellent earnings growth of 50.96%. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 22.60%. TPE ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Could this stock be your next pick? Other fundamental factors you should also consider can be found here.
West African Resources Limited (ASX:WAF)
West African Resources Limited engages in the acquisition, exploration, and development of mineral resource projects in West Africa. Formed in 2006, and currently run by Richard Hyde, the company provides employment to 62 people and with the company’s market cap sitting at AUD A$245.24M, it falls under the small-cap group.
Extreme optimism for WAF, as market analysts projected an outstanding earnings growth rate of 75.62% for the stock, supported by an equally strong sales. It appears that WAF’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 48.10%. WAF’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Thinking of investing in WAF? Check out its fundamental factors here.
Viralytics Limited (ASX:VLA)
Viralytics Limited, a biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies in Australia and internationally. Viralytics is run by CEO Malcolm McColl. With the company’s market capitalisation at AUD A$478.61M, we can put it in the small-cap group